v3.26.1
Stockholders' Equity
 6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Stockholders' Equity

8. Stockholders' Equity

Net Income (loss) Per Common Share

Net income (loss) per common share, as shown on the accompanying Condensed Consolidated Statements of Operations (Unaudited), is determined on the basis of the weighted average number of common shares outstanding during the periods as follows:

 

 

 

For the Quarter Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Weighted average common shares outstanding basic

 

 

37,551,351

 

 

 

37,391,097

 

 

 

37,480,205

 

 

 

37,345,032

 

Dilutive effect of stock options and restricted stock

 

 

240,312

 

 

 

21,840

 

 

 

262,779

 

 

 

84,482

 

Weighted average common shares outstanding diluted

 

 

37,791,663

 

 

 

37,412,937

 

 

 

37,742,984

 

 

 

37,429,514

 

The dilutive effect of stock options and restricted stock was computed using the treasury stock method. The Company also applied the control number concept in the computation of diluted earnings per share to determine whether potential common stock equivalents are dilutive. The control number used is income from continuing operations. The control number concept requires that the same number of potentially dilutive securities applied in computing diluted earnings per share from continuing operations be applied to all other categories of income or loss, regardless of their anti-dilutive effect on such categories.

There were no options to purchase shares of common stock excluded from the computation of diluted earnings per share for the quarter and six months ended June 30, 2026. Options to purchase 10,347 shares of common stock that were outstanding for both the quarter and six months ended June 30, 2025, respectively were not included in the computation of diluted earnings per share as the exercise prices of these options were greater than the average market price of common shares, and were therefore anti-dilutive.